Dosage evidence

Epitalon Dosage: Why There Is No Established Dose

Nomination withdrawn. FDA has not identified safety information for the proposed route.

Where Epitalon stands with the FDA

Compounding nomination withdrawn
FDA has not identified safety-related information regarding epitalon for the proposed route of administration. Therefore, the agency lacks sufficient information to know whether the drug would cause harm if administered to humans.
— US Food and Drug Administration, verbatim

There is no dose to report

No labeled or trial-established human dose was found. The widely repeated epitalon courses trace to a small body of work that does not establish a dose for general use.

We would rather tell you this than publish a number. Pages that rank for “epitalon dosage” routinely state precise-looking figures with no citation attached to them. A number without a source is not more useful than an honest absence — it is less useful, because it looks like it came from somewhere.

Convert your prescribed dose to syringe units

If a clinician has prescribed Epitalon for you, the number that matters next is how far to draw the syringe — and that depends on how much bacteriostatic water went into the vial, not on the peptide itself.

What this does — and what it does not

This converts a dose your prescriber has already given you into a volume and a number of units on a U-100 insulin syringe. It does not suggest a dose, and it does not tell you whether a peptide is appropriate for you. Most research peptides have no FDA-approved dosing, so there is no “standard” number for us to fill in. Doses here are in micrograms (mcg) — confusing mcg with mg is a 1,000-fold error and the single most common way people get this wrong.

Enter the dose your prescriber gave you, in micrograms, to see the volume and syringe units.

Your 5 mg vial in 2 mL of bacteriostatic water is .

Keep reading

References

  1. 1.US Food and Drug Administration. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks — category 2 of the interim policies, and the list of substances nominated but withdrawn. FDA Human Drug Compounding. 2026. https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks

This page reports what regulators and published sources say about Epitalon. It is not medical advice, not a recommendation to use Epitalon, and not a dosing instruction. Every source above was opened and read on the date recorded in our data; regulatory status changes, so check the primary source before relying on it.